Navegar por autor "Olivares Diez, José Manuel"

Modelling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances and disability in outpatients with generalized anxiety disorder (gad) treated in routine clinical practice in Spain

2012- Olivares Diez, José Manuel

Nurses' perceptions of assessment, causes and management of partial/non-adherence to medication: results of the emea adhes survey in schizophrenia

2012- Olivares Diez, José Manuel

Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate

2021- Such, P.; Olivares Diez, José Manuel; Arias, L.; Berg, M. T.; Madera, J. [et al.]

P01-173 - Effect of pregabalin on generalized anxiety disorder patients with severe symptoms of anxiety and depression refractory to duloxetin

2011- Olivares Diez, José Manuel

PATIENT FUNCTIONING IN GENERALIZED ANXIETY DISORDER SUBJECTS WITH PARTIAL RESPONSE TO PRIOR SSRI TREATMENT: THE EFFECT OF ADJUNCTIVE THERAPY WITH PREGABALIN IN DAILY MEDICAL PRACTICE

2013- Olivares Diez, José Manuel

Patterns of Membrane Protein Clustering in Peripheral Lymphocytes as Predictors of Therapeutic Outcomes in Major Depressive Disorder

2019- Caruncho, Hector J.; Rivera Baltanas, Tania; Romay-Tallon, Raquel; Kalynchuk, Lisa E.; Olivares Diez, José Manuel [et al.]

Patterns of Membrane Protein Clustering in Peripheral Lymphocytes as Predictors of Therapeutic Outcomes in Major Depressive Disorder

2019- Caruncho, H. J.; Rivera Baltanas, Tania; Romay-Tallon, R.; Kalynchuk, L. E.; Olivares Diez, José Manuel [et al.]

Pellagra encephalopathy in the context of alcoholism: review and case report

2014- Olivares Diez, José Manuel; López García, Marta

Plasmaβ-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia

2020- Rodrigues-Amorim, D.; Rivera-Baltanás, T.; Del Carmen Vallejo-Curto, M.; Rodriguez-Jamardo, C.; de Las Heras, E.; [et al.]

Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study

2021- Olivares Diez, José Manuel; Gonzalez-Pinto, A.; Páramo Fernández, Mario

Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms

2015- Olivares Diez, José Manuel

Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: A post hoc cost-effectiveness analysis in usual medical practice in Spain

2012- Olivares Diez, José Manuel

Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia

2012- Olivares Diez, José Manuel

Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa

2013- Olivares Diez, José Manuel

Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia-Pacific survey

2013- Olivares Diez, José Manuel

Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia

2012- Olivares Diez, José Manuel

Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy

2014- Olivares Diez, José Manuel

Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder

2012- Olivares Diez, José Manuel; Calado Otero, Maria

Serotonin transporter clustering in blood lymphocytes predicts the outcome on anhedonia scores in naïve depressive patients treated with antidepressant medication

2015- Rivera Baltanas, Tania; Agis Balboa, Roberto Carlos; Romay-Tallon, Raquel; Kalynchuk, Lisa E; Olivares Diez, José Manuel; [et al.]

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine

2020- Rodrígues Amorim, Daniela Sofía; Olivares Diez, José Manuel; Spuch Calvar, Carlos; Rivera-Baltanas, Tania

Repositorio digital RUNA

Navegar por autor "Olivares Diez, José Manuel"

Modelling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances and disability in outpatients with generalized anxiety disorder (gad) treated in routine clinical practice in Spain ﻿

Nurses' perceptions of assessment, causes and management of partial/non-adherence to medication: results of the emea adhes survey in schizophrenia ﻿

Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate ﻿

P01-173 - Effect of pregabalin on generalized anxiety disorder patients with severe symptoms of anxiety and depression refractory to duloxetin ﻿

PATIENT FUNCTIONING IN GENERALIZED ANXIETY DISORDER SUBJECTS WITH PARTIAL RESPONSE TO PRIOR SSRI TREATMENT: THE EFFECT OF ADJUNCTIVE THERAPY WITH PREGABALIN IN DAILY MEDICAL PRACTICE ﻿

Patterns of Membrane Protein Clustering in Peripheral Lymphocytes as Predictors of Therapeutic Outcomes in Major Depressive Disorder ﻿

Patterns of Membrane Protein Clustering in Peripheral Lymphocytes as Predictors of Therapeutic Outcomes in Major Depressive Disorder ﻿

Pellagra encephalopathy in the context of alcoholism: review and case report ﻿

Plasmaβ-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia ﻿

Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study ﻿

Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms ﻿

Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: A post hoc cost-effectiveness analysis in usual medical practice in Spain ﻿

Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia ﻿

Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa ﻿

Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia-Pacific survey ﻿

Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia ﻿

Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy ﻿

Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder ﻿

Serotonin transporter clustering in blood lymphocytes predicts the outcome on anhedonia scores in naïve depressive patients treated with antidepressant medication ﻿

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine ﻿

Modelling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances and disability in outpatients with generalized anxiety disorder (gad) treated in routine clinical practice in Spain

Nurses' perceptions of assessment, causes and management of partial/non-adherence to medication: results of the emea adhes survey in schizophrenia

Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate

P01-173 - Effect of pregabalin on generalized anxiety disorder patients with severe symptoms of anxiety and depression refractory to duloxetin

PATIENT FUNCTIONING IN GENERALIZED ANXIETY DISORDER SUBJECTS WITH PARTIAL RESPONSE TO PRIOR SSRI TREATMENT: THE EFFECT OF ADJUNCTIVE THERAPY WITH PREGABALIN IN DAILY MEDICAL PRACTICE

Patterns of Membrane Protein Clustering in Peripheral Lymphocytes as Predictors of Therapeutic Outcomes in Major Depressive Disorder

Patterns of Membrane Protein Clustering in Peripheral Lymphocytes as Predictors of Therapeutic Outcomes in Major Depressive Disorder

Pellagra encephalopathy in the context of alcoholism: review and case report

Plasmaβ-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia

Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study

Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms

Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: A post hoc cost-effectiveness analysis in usual medical practice in Spain

Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia

Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa

Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia-Pacific survey

Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia

Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy

Serotonin transporter clustering in blood lymphocytes as a putative biomarker of therapeutic efficacy in major depressive disorder

Serotonin transporter clustering in blood lymphocytes predicts the outcome on anhedonia scores in naïve depressive patients treated with antidepressant medication

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine